Prof. Dr Christoph Ernst from the Institute of Medical Microbiology, Immunology and Hygiene at the University Hospital of Cologne and the Faculty of Medicine has been selected for the Boehringer
According to estimates, 4.95 million deaths worldwide in 2019 were directly or indirectly attributable to infections with resistant bacteria. The rising number of resistant bacterial pathogens, also
A team led by Prof Achim Hoerauf in the German Center for Infection Research (DZIF) is further developing the antibiotic corallopyronin A as a treatment for the neglected tropical diseases river
Most antibiotics used in human medicine originate from natural products derived from bacteria and other microbes. Novel microorganisms are therefore a promising source of new active compounds—also for
In a large-scale systematic review, researchers from an international consortium analysed more than 25,000 publications from the last 20 years. They examined the circumstances under which contact
Antimicrobial resistance (AMR) is one of the top global public health and development threats. According to the World Health Organisation (WHO), an estimated 4.95 million deaths were associated with
Many bacteria produce substances to gain an advantage over competitors in their highly competitive natural environment. Researchers at the University Hospital Bonn (UKB), the University of Bonn and
The Presbyterian Hospital in Agogo, Ghana, recorded zero deaths among women during or after childbirth last year. This is a major medical success after 499 fatalities in 2020. The hospital management
Leukaemia is the most common cancer in children. Cancer treatment severely weakens the children's immune system and they can easily develop opportunistic infections. One of the most common causes of
Over 12 million people worldwide suffer from a chronic infection with the hepatitis D virus. This most severe viral liver disease is associated with a high risk of dying from liver cirrhosis and liver